fda warning letters glp-1 september 2025 news and Novo Nordisk Warned of Telehealth Compounding Takedown. What's Next? Beyond the Headlines: FDA Warning

Alimentary Pharmacology and Therapeutics, 11 (2), 409414

Glucagon-like peptide-1 (GLP-1) receptor agonists represent a class of pharmacological agents with both glucose-lowering and weight-reducing effects

Kind Patches have no clinical trials, require no medical oversight, and make no specific weight loss promises beyond customer surveys

Rybelsus led Novos portfolio with an 18% increase, while Ozempic and Victoza saw slower growth at 3.83% and 3.85% respectively

A., Guarino-Vignon, P., Fatouh, R., Dubois, L., Creusot, L., Puchois, V., Amouyal, S., Alonso Salgueiro, I., Bredon, M., Chollet, L., Ledent, T., Scandola, C., Auger, J

Domestic and International Shipping Options: Limitless Life offers two-day shipping via FedEx for all domestic orders